moxifloxacin has been researched along with Wet Macular Degeneration in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Daneman, N; Eng, KT; Kertes, PJ; Kohly, R; Lam, WC; Mandelcorn, E; Schwartz, C; Simor, A; Weisbrod, DJ; Yin, VT | 1 |
Beránek, J; Hejsek, L; Rencová, E; Rozsíval, P; Rysková, L; Studnicka, J | 1 |
2 other study(ies) available for moxifloxacin and Wet Macular Degeneration
Article | Year |
---|---|
Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection.
Topics: Administration, Topical; Aged; Aged, 80 and over; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antibodies, Monoclonal, Humanized; Aza Compounds; Bacteria; Ceftazidime; Cohort Studies; Conjunctiva; Drug Resistance, Multiple, Bacterial; Endophthalmitis; Female; Fluoroquinolones; Hospitals, Teaching; Humans; Intravitreal Injections; Male; Microbial Sensitivity Tests; Moxifloxacin; Prospective Studies; Quinolines; Ranibizumab; Wet Macular Degeneration | 2013 |
[Evaluation of bacterial colonization of the conjunctival sac in ranibizumab intravitreal injections treated patients].
Topics: Aged; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Aza Compounds; Bacteria; Conjunctiva; Drug Combinations; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Intravitreal Injections; Male; Moxifloxacin; Povidone-Iodine; Quinolines; Ranibizumab; Wet Macular Degeneration | 2012 |